...
首页> 外文期刊>The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics >Pharmaceutical industry financial support for medical education: benefit, or undue influence?
【24h】

Pharmaceutical industry financial support for medical education: benefit, or undue influence?

机译:制药业对医学教育的财政支持:是收益还是过度的影响?

获取原文
获取原文并翻译 | 示例
           

摘要

Presently, the pharmaceutical industry funds about half of the costs of continuing medical education (CME) programs in the U.S. This contributes to the ethical problems that pervade the relationship between medicine and the pharmaceutical industry: trustworthiness and conflicts of interest. The problems are exacerbated by rationalizations prevalent on both sides that deny the ethical concerns. Commercialism and commercial bias are highly visible at large CME gatherings, and available data, while scanty, back up the view that physician attendees' subsequent prescribing practices are influenced by the commercial message. The industry believes that it will recoup Dollars 3.56 in increased sales for every dollar that it invests in CME. New guidelines instituted by the Accreditation Council for Continuing Medical Education (ACCME) in 2004 may succeed in reducing excessive commercial influence, especially since the Department of Health and Human Services has also warned the industry of possible anti-kickback violations if firewalls are not erected between CME funding and marketing of drugs. Critics counter that early indicators of improvement are lacking.
机译:目前,制药业为美国继续医学教育(CME)计划花费了大约一半的费用。这加剧了困扰医学与制药业之间关系的道德问题:可信赖性和利益冲突。双方都普遍拒绝接受道德问题的合理化使问题更加恶化。商业主义和商业偏见在大型CME会议上非常明显,可用数据虽然很少,但支持了以下观点,即医师参加者随后的开处方操作受到商业信息的影响。业内人士认为,它在CME上每投资1美元,其销售收入就会增加3.56美元。继续医学教育认证委员会(ACCME)在2004年制定的新指南可能会成功地减少过度的商业影响,尤其是因为卫生与公共服务部还警告业界,如果未在防火墙之间安装防火墙,可能会违反反回扣规定。芝商所的资金和药品营销。批评者认为,缺乏早期改善的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号